OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 56 citing articles:

Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial
Pedro Gutiérrez‐Castrellón, Tania Gandara-Martí, A.T. Abreu y Abreu, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 155

Probiotics for preventing acute upper respiratory tract infections
Yunli Zhao, Bi Rong Dong, Qiukui Hao
Cochrane library (2022) Vol. 2022, Iss. 8
Open Access | Times Cited: 68

Role of Probiotics against Human Cancers, Inflammatory Diseases, and Other Complex Malignancies
Hammad Naeem, Hammad Ul Hassan, Muhammad Shahbaz, et al.
Journal of Food Biochemistry (2024) Vol. 2024, pp. 1-23
Open Access | Times Cited: 14

Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2

Akkermansia muciniphila and its outer protein Amuc_1100 regulates tryptophan metabolism in colitis
Zhen-Yang Gu, Wenlong Pei, Yonghua Shen, et al.
Food & Function (2021) Vol. 12, Iss. 20, pp. 10184-10195
Closed Access | Times Cited: 89

Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
Guanglin Cui, Qingbo Fan, Zhenfeng Li, et al.
EBioMedicine (2021) Vol. 66, pp. 103329-103329
Open Access | Times Cited: 70

The role of fecal sulfur metabolome in inflammatory bowel diseases
Alesia Walker, Philippe Schmitt‐Kopplin
International Journal of Medical Microbiology (2021) Vol. 311, Iss. 5, pp. 151513-151513
Open Access | Times Cited: 55

Cross-talk between immune system and microbiota in COVID-19
Shaghayegh Baradaran Ghavami, Mahsa Pourhamzeh, Maryam Farmani, et al.
Expert Review of Gastroenterology & Hepatology (2021) Vol. 15, Iss. 11, pp. 1281-1294
Open Access | Times Cited: 44

Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19
Markus F. Neurath, Klaus Überla, Siew C. Ng
Gut (2021) Vol. 70, Iss. 9, pp. 1605-1608
Open Access | Times Cited: 43

A Predictive Model Based on the Gut Microbiota Improves the Diagnostic Effect in Patients With Cholangiocarcinoma
Tan Zhang, Sina Zhang, Chen Jin, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 43

Impact of early-life rearing history on gut microbiome succession and performance of Nile tilapia
Yale Deng, Fotini Kokou, Ep H. Eding, et al.
Animal Microbiome (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 41

COVID-19: Gastrointestinal manifestations, liver injury and recommendations
Zülal Özkurt, Esra Çınar Tanrıverdi
World Journal of Clinical Cases (2022) Vol. 10, Iss. 4, pp. 1140-1163
Open Access | Times Cited: 31

Gut Microbiota and Probiotics/Synbiotics for Modulation of Immunity in Critically Ill Patients
Kentaro Shimizu, Masahiro Ojima, Hiroshi Ogura
Nutrients (2021) Vol. 13, Iss. 7, pp. 2439-2439
Open Access | Times Cited: 35

Assessment of Lab4P Probiotic Effects on Cognition in 3xTg-AD Alzheimer’s Disease Model Mice and the SH-SY5Y Neuronal Cell Line
Thomas S. Webberley, Ryan J. Bevan, Joshua Kerry-Smith, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4683-4683
Open Access | Times Cited: 12

Time-course alterations of gut microbiota and short-chain fatty acids after short-term lincomycin exposure in young swine
Shanlong Tang, Shunfen Zhang, Ruqing Zhong, et al.
Applied Microbiology and Biotechnology (2021) Vol. 105, Iss. 21-22, pp. 8441-8456
Open Access | Times Cited: 28

The link among microbiota, epigenetics, and disease development
Amr El-Sayed, Lotfi Aleya, Mohamed Kamel
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 23, pp. 28926-28964
Closed Access | Times Cited: 27

Exposure to High Aerial Ammonia Causes Hindgut Dysbiotic Microbiota and Alterations of Microbiota-Derived Metabolites in Growing Pigs
Shanlong Tang, Ruqing Zhong, Chang Yin, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 26

Immunomodulatory Effects of Probiotics on COVID-19 Infection by Targeting the Gut–Lung Axis Microbial Cross-Talk
Kalliopi D. Synodinou, Maroulla D. Nikolaki, Konstantinos Triantafyllou, et al.
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1764-1764
Open Access | Times Cited: 15

An insight into the health beneficial of probiotics dairy products: a critical review
JinTao He, Wen Li, Jing Deng, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 32, pp. 11290-11309
Closed Access | Times Cited: 14

Gut microbiota dysbiosis is associated with sepsis‐induced cardiomyopathy in patients: A case‒control study
Fan Deng, Yu Chen, Qi‐Shun Sun, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Closed Access | Times Cited: 14

Change in the Gut Microbiome and Immunity by Lacticaseibacillusrhamnosus Probio-M9
Meng Zhang, Yan Zheng, Zheng Sun, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 8

Interplay between Multisystem Inflammatory Syndrome in Children, Interleukin 6, Microbiome, and Gut Barrier Integrity
Ali Zari, Elrashdy M. Redwan, Mikolaj Raszek, et al.
Immuno (2024) Vol. 4, Iss. 3, pp. 226-246
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top